Atara Biotherapeutics, Inc. (ATRA)

NASDAQ: ATRA · Real-Time Price · USD

6.90

+0.67 (10.75%)

At close: Mar 12, 2026, 4:00 PM EDT

6.78

-0.12 (-1.74%)

After-hours: Mar 12, 2026, 4:19 PM EDT

Atara Biotherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	151.93	128.94	8.57	63.57	20.34	-
Revenue Growth (YoY)	51.27%	1404.02%	-86.52%	212.55%	-	-
Cost of Revenue	27.9	21.01	8.89	-	-	-
Gross Profit	124.03	107.93	-0.31	63.57	20.34	-
Selling, General & Admin	31.42	39.89	50.91	71.55	78.8	64.4
Research & Development	66.39	151.48	224.79	272.53	282	244.65
Total Operating Expenses	97.81	191.37	275.69	344.09	360.8	309.05
Operating Income	26.22	-83.44	-276.01	-280.51	-340.46	-309.05
Interest Income	1.18	2.11	5.43	3.06	-	-
Interest Expense	-3.92	-4.62	-5.29	-0.37	-	-
Other Non-Operating Income (Expense)	-0.07	0.53	-0.25	49.54	-	-
Total Non-Operating Income (Expense)	-3.32	-1.98	-0.11	52.22	0.73	4.89
Pretax Income	23.41	-85.42	-276.11	-228.29	-340.1	-306.61
Provision for Income Taxes	0.01	-0.01	0.02	0.01	0.05	0.02
Net Income	23.4	-85.4	-276.13	-228.3	-340.14	-306.62
Net Income to Common	23.4	-85.4	-276.13	-228.3	-340.14	-306.62
Shares Outstanding (Basic)	12	7	4	4	4	3
Shares Outstanding (Diluted)	12	7	4	4	4	3
Shares Change (YoY)	101.28%	76.77%	3.83%	8.88%	26.63%	44.17%
EPS (Basic)	2.22	-11.41	-65.19	-56.00	-90.75	-103.75
EPS (Diluted)	2.18	-11.41	-65.19	-56.00	-90.75	-103.75
Free Cash Flow	-69.8	-68.96	-194.2	-274.62	-231.1	-185.27
Free Cash Flow Per Share	-5.89	-9.21	-45.85	-67.32	-61.68	-62.61
Gross Margin	14.81%	83.71%	-3.65%	100.00%	100.00%	-
Operating Margin	80.06%	-64.71%	-3219.48%	-441.25%	-1673.85%	-
Profit Margin	71.45%	-66.23%	-3220.88%	-359.12%	-1672.28%	-
FCF Margin	-213.12%	-53.48%	-2265.25%	-431.98%	-1136.19%	-
EBITDA	29.39	-78.39	-271.18	-274.86	-331.12	-300.72
EBITDA Margin	89.73%	-60.79%	-3163.15%	-432.35%	-1627.91%	-
EBIT	26.22	-83.44	-276.01	-280.51	-340.46	-309.05
EBIT Margin	80.06%	-64.71%	-3219.48%	-441.25%	-1673.85%	-
Effective Tax Rate	0.05%	0.01%	-0.01%	-0.01%	-0.01%	-0.00%

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q